Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2017

01-03-2017 | Original Article

Thyroid function and autoimmunity are associated with the risk of vertebral fractures in postmenopausal women

Authors: Irene Lambrinoudaki, Eleni Armeni, Paraskevi Pliatsika, Demetrios Rizos, George Kaparos, Areti Augoulea, Andreas Alexandrou, Maria Flokatoula, Maria Creatsa, Constantinos Panoulis, Nikolaos Triantafyllou, Xenofon Papacharalambous

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2017

Login to get access

Abstract

Overt or subclinical thyroid dysfunction may affect the risk of fragility fractures. The aim of the present study was to assess the association of thyroid function and autoimmunity with vertebral fractures (VF) in a large sample of Greek postmenopausal women. This cross-sectional study recruited 335 euthyroid postmenopausal women, aged 35–79 years. Euthyroidism was verified by serum thyroid-stimulating hormone (TSH) within the laboratory reference range (0.4–4.5 μIU/mL). VFs were diagnosed by lumbar spine lateral radiographs, according to quantitative procedures. Serum free triiodothyronine (FT3), free thyroxine (FT4), TSH, as well as levels of anti-thyroglobulin (anti-TG) and thyroid peroxidase antibodies (anti-TPO) were compared according to the presence of VFs. Multivariate logistic regression showed that the presence of VFs was predicted independently by ln-TSH levels (OR = 0.290, p = 0.037) and positive anti-TG antibodies (OR = 3.308, p = 0.026) in models adjusted for age, menopausal age, and ln-HOMA-IR. Stepwise logistic regression analysis showed that the presence of VFs was predicted by menopausal age (OR = 1.120, p = 0.001), ln-TSH (OR = 0.312, p = 0.052), and thyroid autoimmunity (anti-TG and anti-TPO positive: OR = 6.637, p = 0.007) in a model that also included age and ln-HOMA-IR. Women with lower circulating TSH had higher risk of having a VF, independently of age, menopausal age, and insulin resistance. The presence of positive anti-TG/anti-TPO antibodies also indicated an elevated risk of fracture. Levels of thyroid hormones had no apparent effect on the risk of fracture. Further studies are necessary to establish the significance of our findings.
Literature
1.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
2.
go back to reference Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed
3.
go back to reference Ensrud KE, Schousboe JT (2011) Clinical practice. Vertebral fractures. N Engl J Med 364:1634–1642CrossRefPubMed Ensrud KE, Schousboe JT (2011) Clinical practice. Vertebral fractures. N Engl J Med 364:1634–1642CrossRefPubMed
4.
go back to reference Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR (2009) FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res 24:1793–1799CrossRefPubMed Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR (2009) FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res 24:1793–1799CrossRefPubMed
5.
go back to reference Briggs AM, Greig AM, Wark JD (2007) The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 18:575–584CrossRefPubMed Briggs AM, Greig AM, Wark JD (2007) The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 18:575–584CrossRefPubMed
6.
go back to reference Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256CrossRefPubMedPubMedCentral Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256CrossRefPubMedPubMedCentral
7.
go back to reference Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed
8.
go back to reference Waung JA, Bassett JH, Williams GR (2012) Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab 23:155–162CrossRefPubMed Waung JA, Bassett JH, Williams GR (2012) Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab 23:155–162CrossRefPubMed
9.
go back to reference Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR et al (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313:2055–2065CrossRefPubMedPubMedCentral Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR et al (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313:2055–2065CrossRefPubMedPubMedCentral
10.
go back to reference Yan Z, Huang H, Li J, Wang J (2015) Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies. Osteoporos Int 30:30 Yan Z, Huang H, Li J, Wang J (2015) Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies. Osteoporos Int 30:30
11.
go back to reference Polovina S, Micic D, Miljic D, Milic N, Popovic V (2015) The Fracture Risk Assessment Tool (FRAX score) in subclinical hyperthyroidism. Vojnosanit Pregl 72:510–516CrossRefPubMed Polovina S, Micic D, Miljic D, Milic N, Popovic V (2015) The Fracture Risk Assessment Tool (FRAX score) in subclinical hyperthyroidism. Vojnosanit Pregl 72:510–516CrossRefPubMed
12.
go back to reference Polovina S, Popovic V, Duntas L, Milic N, Micic D (2013) Frax score calculations in postmenopausal women with subclinical hypothyroidism. Hormones 12:439–448PubMed Polovina S, Popovic V, Duntas L, Milic N, Micic D (2013) Frax score calculations in postmenopausal women with subclinical hypothyroidism. Hormones 12:439–448PubMed
13.
go back to reference Tuchendler D, Bolanowski M (2014) The influence of thyroid dysfunction on bone metabolism. Thyroid Res 7:0012–0014CrossRef Tuchendler D, Bolanowski M (2014) The influence of thyroid dysfunction on bone metabolism. Thyroid Res 7:0012–0014CrossRef
14.
go back to reference Bassett JH, Williams GR (2008) Critical role of the hypothalamic–pituitary–thyroid axis in bone. Bone 43:418–426CrossRefPubMed Bassett JH, Williams GR (2008) Critical role of the hypothalamic–pituitary–thyroid axis in bone. Bone 43:418–426CrossRefPubMed
15.
go back to reference Mazziotti G, Porcelli T, Patelli I, Vescovi PP, Giustina A (2010) Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 46:747–751CrossRefPubMed Mazziotti G, Porcelli T, Patelli I, Vescovi PP, Giustina A (2010) Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 46:747–751CrossRefPubMed
16.
go back to reference Leader A, Ayzenfeld RH, Lishner M, Cohen E, Segev D, Hermoni D (2014) Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years. J Clin Endocrinol Metab 99:2665–2673CrossRefPubMed Leader A, Ayzenfeld RH, Lishner M, Cohen E, Segev D, Hermoni D (2014) Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years. J Clin Endocrinol Metab 99:2665–2673CrossRefPubMed
17.
go back to reference Abrahamsen B, Jorgensen HL, Laulund AS, Nybo M, Brix TH, Hegedus L (2014) Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures—the OPENTHYRO register cohort. J Bone Miner Res 29:2040–2050CrossRefPubMed Abrahamsen B, Jorgensen HL, Laulund AS, Nybo M, Brix TH, Hegedus L (2014) Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures—the OPENTHYRO register cohort. J Bone Miner Res 29:2040–2050CrossRefPubMed
18.
go back to reference Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R et al (2010) Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 95:3173–3181CrossRefPubMed Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R et al (2010) Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 95:3173–3181CrossRefPubMed
19.
go back to reference Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjoro T et al (2013) Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol 169:845–852CrossRefPubMed Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjoro T et al (2013) Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol 169:845–852CrossRefPubMed
20.
go back to reference LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS (2007) Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 14:191–202CrossRefPubMed LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS (2007) Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 14:191–202CrossRefPubMed
21.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMed
22.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed
23.
go back to reference Saltiki K, Voidonikola P, Stamatelopoulos K, Mantzou E, Papamichael C, Alevizaki M (2008) Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-sectional study. Thyroid Res 1:3CrossRefPubMedPubMedCentral Saltiki K, Voidonikola P, Stamatelopoulos K, Mantzou E, Papamichael C, Alevizaki M (2008) Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-sectional study. Thyroid Res 1:3CrossRefPubMedPubMedCentral
24.
go back to reference Schmidt S, Schelde B, Norgaard K (2014) Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review. Diabetes Med 31:886–896CrossRef Schmidt S, Schelde B, Norgaard K (2014) Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review. Diabetes Med 31:886–896CrossRef
25.
go back to reference Gillespie SJ, Kulkarni KD, Daly AE (1998) Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 98:897–905CrossRefPubMed Gillespie SJ, Kulkarni KD, Daly AE (1998) Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 98:897–905CrossRefPubMed
26.
go back to reference Fitch C, Keim KS (2012) Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet 112:739–758CrossRefPubMed Fitch C, Keim KS (2012) Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet 112:739–758CrossRefPubMed
27.
go back to reference Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC (2010) The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care 33:1859–1864CrossRefPubMedPubMedCentral Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC (2010) The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care 33:1859–1864CrossRefPubMedPubMedCentral
28.
go back to reference Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ (2012) Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care 35:446–454CrossRefPubMedPubMedCentral Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ (2012) Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care 35:446–454CrossRefPubMedPubMedCentral
29.
go back to reference Standl E, Erbach M, Schnell O (2013) Glycemic control: a combination of lifestyle management and the use of drugs. Cardiol Ther 2:1–16CrossRefPubMed Standl E, Erbach M, Schnell O (2013) Glycemic control: a combination of lifestyle management and the use of drugs. Cardiol Ther 2:1–16CrossRefPubMed
30.
go back to reference Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed
31.
go back to reference Shi Y, Sun M, Wang Z, Fu Q, Cao M, Zhu Z et al (2014) Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study. Endocrine 47:227–233CrossRefPubMed Shi Y, Sun M, Wang Z, Fu Q, Cao M, Zhu Z et al (2014) Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study. Endocrine 47:227–233CrossRefPubMed
32.
go back to reference McLachlan SM, Rapoport B (2004) Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 14:510–520CrossRefPubMed McLachlan SM, Rapoport B (2004) Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 14:510–520CrossRefPubMed
33.
go back to reference van Rijn LE, Pop VJ, Williams GR (2014) Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women. Eur J Endocrinol 170:461–468CrossRefPubMed van Rijn LE, Pop VJ, Williams GR (2014) Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women. Eur J Endocrinol 170:461–468CrossRefPubMed
Metadata
Title
Thyroid function and autoimmunity are associated with the risk of vertebral fractures in postmenopausal women
Authors
Irene Lambrinoudaki
Eleni Armeni
Paraskevi Pliatsika
Demetrios Rizos
George Kaparos
Areti Augoulea
Andreas Alexandrou
Maria Flokatoula
Maria Creatsa
Constantinos Panoulis
Nikolaos Triantafyllou
Xenofon Papacharalambous
Publication date
01-03-2017
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2017
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-016-0752-0

Other articles of this Issue 2/2017

Journal of Bone and Mineral Metabolism 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine